U2Bio Co., Ltd. (221800)
Market Open
11 Aug, 05:26
KRX SM KRX SM Primary ₩
4,305. 00
+200
+4.8721%
₩
254.53B Market Cap
- P/E Ratio
120% Div Yield
1.68M Volume
- Eps
₩ 4,105
Previous Close Want to track 221800 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
U2Bio Co., Ltd. (221800) Statistics
Valuation metrics
Market Cap 254.53B
Enterprise value 277.17B
Trailing P/E (ttm) -
Forward P/E 37.61
PEG ratio -
Price/Sales (ttm) 8.38
Price/Book (mrq) -
Enterprise Value/Revenue 10.83
Enterprise Value/EBITDA -204.25
Overview
Shares outstanding 11.29M
Float 6.87M
Shares short -
% Held by insiders 0.39%
% Held by institutions 0%
Average volume (10 days) 555.96K
Average volume (90 days) 2.58M
Price summary
52-Week low 3,020
52-Week high 32,800
Beta 1.74
50-Day moving average 14,073.9
200-Day moving average 6,334.38
Dividends and splits
Forward annual dividend rate 120
Forward annual dividend yield 0.0056%
Trailing annual dividend rate 30
Trailing annual dividend yield 0.0014%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 3 Jan 2025
Ex-Dividend Date 27 Dec 2024
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.06%
Operating margin -0.13%
Operational effectiveness
Return on assets -0.03%
Return on equity -0.04%
Income Statement
Revenue (ttm) 25.59B
Revenue per share (ttm) 2,197.64
Quarterly revenue growth (yoy) 0%
Gross profit (ttm) 5.39B
EBITDA -1.36B
Net income to common (ttm) -1.64B
Diluted EPS (ttm) -
Quarterly earnings growth (yoy) 0%
Balance Sheet
Total cash (mrq) 31.77B
Total cash per share (mrq) 2,497.12
Total debt (mrq) 442.62M
Total Debt/Equity (mrq) 1.05
Current ratio (mrq) 6.39%
Book value per share (mrq) -
Cash Flow
Cash flow statement -1.56B
Levered free cash flow (LFCF) -1.88B
